Quantcast

Latest Attention-deficit hyperactivity disorder management Stories

2009-12-03 08:00:00

PHILADELPHIA, Dec. 3 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot of the Attention-Deficit/Hyperactivity Disorder (ADHD) patch Daytrana®.

2009-11-16 16:23:29

Primary objective of the study was to evaluate the safety of coadministration of INTUNIV with stimulants.

2009-11-16 08:00:00

PHILADELPHIA, Nov. 16 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced new study results on INTUNIV(TM) (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology.

2009-10-30 17:18:18

INTUNIV, recently approved by the FDA as the first nonscheduled alpha-2A agonist indicated for the treatment of ADHD in children and adolescents, will soon be available in pharmacies nationwide.

2009-10-29 23:29:52

Following is a summary of the key Shire scientific presentations.


Word of the Day
coulisse
  • One of the side scenes of the stage in a theater, or the space included between the side scenes.
  • The outside stock exchange, or “curb market,” of Paris.
  • A flute or groove on the blade of a sword.
  • A section of stage scenery placed in a wing of a theatre.
The word 'coulisse' comes from a French word meaning "sliding door".
Related